One in eight people on earth lives with a mental health disorder. That is 970 million people — a number larger than the entire population of the Western Hemisphere — and it represents only those cases that have been identified and counted. The actual burden of mental illness worldwide is almost certainly higher, given that most low- and middle-income countries conduct little population-level mental health screening. The World Health Organization has described the global state of mental health as 'a silent crisis hidden in plain sight.'
Yet the data in 2026 is not uniformly grim. Stigma around mental health treatment is declining, particularly among younger generations. Telehealth has dramatically expanded access to therapy in high-income countries. Several previously inexorable negative trends — suicide rates, for instance — showed some improvement in the early 2020s. What the numbers reveal when examined carefully is a picture of profound inequality: a condition in which mental illness is ubiquitous, treatment is transformative, and access to that treatment is distributed with stunning unfairness based on income, geography, and age.
This article compiles the most current, well-sourced statistics on mental health prevalence, treatment access, economic cost, youth crisis indicators, and what is and is not improving. The data comes primarily from WHO, the CDC, SAMHSA, the Lancet, and major peer-reviewed research. Where statistics are widely cited but poorly sourced — a frequent problem in mental health journalism — this piece notes the uncertainty.
"Mental health is not a luxury — it is foundational to everything. The fact that 75% of people with mental illness in low-income countries receive no care at all is not a technical or budgetary challenge. It is a moral failure." — Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, 2024
Key Definitions
Mental Disorder: A clinically significant disturbance in cognition, emotional regulation, or behavior that reflects dysfunction in psychological, biological, or developmental processes underlying mental functioning. Includes conditions such as depression, anxiety disorders, bipolar disorder, schizophrenia, eating disorders, and PTSD. Defined and classified in the DSM-5 (American Psychiatric Association) and ICD-11 (WHO).
Treatment Gap: The proportion of people with a diagnosable mental disorder who receive no treatment in a given period. The treatment gap is calculated as the difference between true prevalence and treated prevalence. It is consistently one of the largest treatment gaps of any disease category.
Disability-Adjusted Life Year (DALY): A measure of overall disease burden combining years of life lost to early death and years lived with disability or illness. Used by WHO and the Global Burden of Disease project to compare the impact of different conditions across populations.
Serious Mental Illness (SMI): A subset of mental disorders — primarily schizophrenia, bipolar disorder, and major depressive disorder — that substantially interferes with daily functioning. SMI affects approximately 1 in 25 US adults, or 13.1 million people.
Prevalence vs. Incidence: Prevalence is the proportion of a population with a condition at a given time. Incidence is the rate of new cases. Mental health statistics typically report prevalence, which accumulates over time and is substantially larger than incidence.
Global Prevalence of Depression and Anxiety
Depression and anxiety are the two most common mental disorders globally and account for the majority of mental health disability burden. According to WHO's most recent comprehensive estimates, 280 million people worldwide live with depression — making it one of the leading causes of disability worldwide. Anxiety disorders affect 301 million people globally, the largest single mental health diagnostic category.
These are not merely mild experiences of sadness or worry. Clinical depression (major depressive disorder) and generalized anxiety disorder cause significant functional impairment: difficulty working, maintaining relationships, managing basic self-care, and in severe cases, sustaining the will to live. WHO data shows that depression is a leading contributor to global DALYs (disability-adjusted life years), ranking among the top 10 causes of disability worldwide.
The COVID-19 pandemic triggered a significant upswing in both conditions. A 2022 Lancet study estimated that the pandemic caused an additional 53 million cases of major depressive disorder and 76 million cases of anxiety disorder in its first year alone — increases of approximately 28% and 26% respectively above pre-pandemic baselines. WHO's subsequent global survey data, published in 2023, confirmed that much of this increase remained, particularly among younger adults, women, and people in countries with high COVID-19 mortality and severe lockdown measures.
Cross-national prevalence data shows that high-income countries do not necessarily have higher rates of mental illness — but they have dramatically higher rates of diagnosis and treatment. The United States reports some of the highest lifetime prevalence rates in the world (approximately 47% of adults will meet criteria for a diagnosable mental disorder at some point in their lives, per National Comorbidity Survey data), reflecting partly genuine burden and partly greater diagnostic infrastructure and openness to mental health labeling.
The Treatment Gap: A Global Inequality
The mental health treatment gap is the defining public health problem in this field. The figures are stark and largely unchanged despite decades of advocacy.
WHO estimates that more than 75% of people with mental health conditions in low- and middle-income countries receive no care. In some low-income countries, the proportion receiving no treatment exceeds 95%. In Ethiopia, one of the world's most populous countries, there are approximately 0.5 psychiatrists per 100,000 population. In the United States, there are approximately 17 per 100,000. The infrastructure gap between rich and poor countries in mental health is among the most extreme of any health sector.
Even in high-income countries, the treatment gap remains substantial. SAMHSA's 2024 National Survey on Drug Use and Health found that 57.8 million US adults (22.5% of the adult population) had a mental illness in the past year. Of those, only 47% received any form of mental health treatment. For young adults aged 18-25 with serious mental illness, the treatment rate was 70% — higher than the population average, but still leaving 30% without care.
In the United Kingdom, NHS England's 2025 data shows that adult mental health referral-to-treatment waits exceed 18 weeks for one-third of patients. More than 1.8 million people were on NHS mental health waiting lists as of early 2025. In Australia, the average wait time for a publicly funded psychologist appointment exceeds 6 months in rural and regional areas.
The reasons for the treatment gap are well understood: cost (private therapy in the US averages $150-$250 per session, with significant insurance barriers), stigma (particularly in South and East Asian cultures and among older generations and men of most cultures), geographic access (rural and low-income areas have severe provider shortages), and simple lack of awareness that effective treatments exist.
The Youth Mental Health Crisis
No dimension of the global mental health data has attracted more attention in recent years than the deterioration of mental health among young people. The trends are consistent across multiple data sources and multiple countries, and they are severe enough that the US Surgeon General, the American Psychological Association, the British government, and the Australian government have all characterized the situation as a public health emergency.
CDC data shows that the percentage of US high school students reporting persistent feelings of sadness or hopelessness rose from 28% in 2011 to 42% in 2023. Among adolescent girls, the figure reached 57% — meaning more than half of teenage girls in the United States report persistent feelings consistent with clinical depression criteria. Among LGBTQ+ youth, 69% reported persistent sadness or hopelessness.
Emergency department visits for self-harm among girls aged 10-14 more than doubled between 2010 and 2022 in the United States, according to CDC's WONDER database. Eating disorder hospitalizations among adolescents increased 40% between 2016 and 2022. Suicide rates among young people aged 10-24 increased from 6.8 per 100,000 in 2007 to 11.0 per 100,000 in 2021 before showing a slight moderation in 2022-2023 data.
The UK's NHS Digital data for 2024-2025 showed that one in five children aged 8-16 had a probable mental disorder — up from one in nine in 2017. Child and adolescent mental health service (CAMHS) referrals reached record highs for the third consecutive year in 2024-2025. Australia, Canada, and most Western European countries report similar trajectories.
Researchers disagree about cause. Social psychologist Jonathan Haidt and psychologist Jean Twenge argue that smartphone adoption and social media use are primary drivers, noting the timing correlation with the 2012-2015 period when smartphones became near-universal among adolescents. Other researchers, including psychologist Andrew Przybylski, argue the social media effect is small and that economic insecurity, climate anxiety, academic pressure, and reduced unstructured childhood play are more significant factors. The 2025 ABCD (Adolescent Brain Cognitive Development) study, one of the largest longitudinal studies of US child development, found statistically significant associations between heavy social media use and reduced cognitive development, lending credibility to Haidt's position.
Rates by Disorder Type
Beyond depression and anxiety, the epidemiological landscape of mental health includes several other major conditions.
Schizophrenia affects approximately 24 million people worldwide, or 1 in 300 of the global population, per WHO. It is characterized by high disability burden (significant functional impairment in most cases), significant mortality risk (people with schizophrenia die on average 10-20 years earlier than the general population, primarily from cardiovascular disease, diabetes, and suicide), and treatment gaps exceeding 89% in low-income countries. Effective antipsychotic treatments exist but require consistent access and monitoring.
Bipolar disorder affects approximately 40 million people worldwide (WHO). US lifetime prevalence is approximately 4.4% for the full spectrum including bipolar II and cyclothymia, per NCS-R data. Bipolar disorder is associated with extremely high rates of suicide attempt: approximately 30% of people with bipolar I disorder will attempt suicide at least once.
PTSD affects an estimated 3.9% of the global population, per WHO, with dramatically higher rates among conflict-affected populations, refugee communities, and survivors of trauma. US veteran populations show PTSD rates of approximately 11-20% depending on the era and theater of service.
Eating disorders — anorexia nervosa, bulimia nervosa, and binge eating disorder — affect approximately 9% of the global population at some point in their lives, per the National Eating Disorders Association. Anorexia nervosa has the highest mortality rate of any psychiatric disorder, with approximately 10% of those with the condition dying from it.
Substance use disorders complicate the mental health picture enormously. Approximately 50% of people with a substance use disorder also have a co-occurring mental health condition, a pattern referred to as 'dual diagnosis.' In the United States, approximately 21.5 million adults had a co-occurring mental illness and substance use disorder in 2023, per SAMHSA.
Economic Cost of Mental Illness
The economic burden of mental illness is staggering by any measure. The Lancet Commission on global mental health estimated that the cumulative global economic cost of mental disorders between 2011 and 2030 would reach $16 trillion — exceeding the cost of cancer, cardiovascular disease, diabetes, and respiratory disease combined.
In the United States, the National Alliance on Mental Illness estimates the annual economic cost of serious mental illness alone exceeds $300 billion, including direct treatment costs, reduced earnings, Social Security Disability payments, and criminal justice involvement. The total economic burden of all mental disorders in the US — including mild to moderate conditions — is estimated at $500 billion or more annually.
Employer costs are significant and measurable. Depression costs US employers approximately $44 billion annually in lost productivity, according to research published in the Journal of Clinical Psychiatry. Anxiety costs an estimated $31 billion. Presenteeism — reduced productivity while physically present at work due to mental health symptoms — accounts for approximately 70% of that cost, with absenteeism accounting for the remaining 30%. This ratio underscores that mental health's economic impact is largely invisible: most affected workers show up, but perform below capacity.
Conversely, treatment is highly cost-effective. A 2016 Lancet Psychiatry study estimated that every $1 invested in scaled-up treatment for depression and anxiety disorders yielded a $4 return in improved health and ability to work. More recent studies confirm returns in the range of $3-5 per dollar invested, making mental health treatment among the most cost-effective health investments available. The treatment gap thus represents not merely a moral failure but an economic one.
Therapy Access and the Telehealth Revolution
Telehealth has been the single most significant structural development in mental health access in the past five years. The number of Americans receiving remote mental health services grew from under 1 million in 2019 to approximately 17 million in 2024, according to the American Psychological Association's practice survey data.
The COVID-19 pandemic forced an overnight shift to telehealth across mental health disciplines and forced regulatory changes that had previously seemed politically impossible: Medicare and Medicaid expanded telehealth reimbursement, many states granted temporary licensing reciprocity to allow therapists to see patients across state lines, and privacy regulations were relaxed to allow video sessions over standard platforms. Many of these emergency provisions have since been made permanent.
The impact on access has been real, though uneven. Urban and suburban patients with reliable broadband and familiarity with video technology benefited most. Rural patients, elderly patients, and low-income patients with limited technology access benefited less. A 2024 JAMA Psychiatry study found that telehealth mental health use was 3.4x higher among patients in the highest income quintile compared to the lowest, suggesting that telehealth expansion has partially reproduced existing access inequalities rather than eliminating them.
Medication management via telehealth — including prescription of psychiatric medications after video consultation — has grown substantially. Platforms like Cerebral, Done, and Talkiatry saw explosive growth, though regulatory scrutiny has increased following concerns about overprescription of stimulants and controlled substances via telehealth-only models. The FDA and DEA tightened rules on telehealth prescribing of Schedule II and III controlled substances in 2024.
What Is Actually Improving
Against the weight of difficult statistics, some genuine positive trends are worth documenting.
Suicide rates in the United States declined from their 2018 peak of 14.2 per 100,000 to 13.2 per 100,000 in 2022, per CDC mortality data — a meaningful improvement. The drivers are unclear and likely multiple, including expanded crisis resources (the 988 Suicide and Crisis Lifeline, launched in 2022, received over 10 million contacts in its first two years), medication and therapy improvements, and changing cultural norms. Preliminary 2024 data suggests the trend may have modestly reversed, warranting continued monitoring.
Stigma has demonstrably declined among younger generations. American Psychological Association survey data shows that 64% of Gen Z adults report being comfortable seeking professional mental health help, compared to 48% of Millennials, 40% of Gen X, and 31% of Boomers. Celebrity and athlete openness about mental health struggles — from Simone Biles to Prince Harry to Naomi Osaka — has demonstrably shifted public attitudes. Google Trends data shows a 380% increase in searches for 'therapy' and 'therapist near me' between 2015 and 2025.
Global mental health funding has increased, though from a very low baseline. The WHO's Special Initiative for Mental Health (2019-2023) reached approximately 100 million people with expanded mental health services. The World Bank and major philanthropic organizations have substantially increased mental health funding in low- and middle-income countries. Globally, governments spend an average of 2.1% of their health budgets on mental health (WHO, 2023) — up from 1.8% in 2018, but still far short of the 5% WHO recommends.
Practical Implications
For individuals, the most important implication of the treatment gap data is straightforward: if you or someone you know is struggling, seeking help is both highly effective and more socially accepted than at any previous point in history. The barrier is increasingly practical (cost, waitlists) rather than social stigma, particularly for younger adults.
For employers, the business case for workplace mental health investment is robust. Returns of $3-5 per dollar invested, combined with the demonstrated productivity costs of untreated mental illness, make comprehensive Employee Assistance Programs and mental health benefit coverage one of the most defensible wellness investments available.
For policymakers, the data argues for three interventions above all others: expanding the mental health workforce through loan forgiveness, training subsidies, and scope-of-practice expansion; removing cost barriers through insurance parity enforcement and public program expansion; and investing heavily in prevention — particularly youth mental health programs in schools.
References
- World Health Organization. (2022). World Mental Health Report: Transforming Mental Health for All. who.int.
- SAMHSA. (2024). National Survey on Drug Use and Health 2023. samhsa.gov.
- CDC. (2024). Youth Risk Behavior Survey 2023. cdc.gov.
- Lancet Commission on Global Mental Health. (2018, updated 2023). The Lancet Commission on Global Mental Health and Sustainable Development. thelancet.com.
- GBD Mental Disorders Collaborators. (2022). Global prevalence and burden of depressive and anxiety disorders in 204 countries. The Lancet, 398(10312).
- American Psychological Association. (2025). Stress in America Survey 2025. apa.org.
- NHS Digital. (2025). Mental Health of Children and Young People in England 2024. digital.nhs.uk.
- National Alliance on Mental Illness. (2025). Mental Health By the Numbers. nami.org.
- Patel, V., et al. (2018). The Lancet Commission on global mental health and sustainable development. The Lancet, 392(10157).
- Twenge, J.M. (2023). Generations. Atria Books.
- ABCD Study Investigators. (2025). Screen media use and mental health longitudinal outcomes. JAMA Pediatrics.
- Chisholm, D., et al. (2016). Scaling-up treatment of depression and anxiety. The Lancet Psychiatry, 3(5).
Frequently Asked Questions
How many people globally have a mental health disorder?
The World Health Organization estimates that approximately 1 in 8 people worldwide — roughly 970 million people — live with a mental disorder. Depression and anxiety are the most common, affecting 280 million and 301 million people respectively as of 2023 (the most recent comprehensive WHO global estimates, with 2025 updates pending). These figures likely undercount actual prevalence due to significant underdiagnosis in low- and middle-income countries, where mental health screening is rare. The COVID-19 pandemic triggered a substantial increase: WHO estimates a 25% increase in the prevalence of anxiety and depression in the first year of the pandemic alone, and longitudinal data suggest much of that increase has not fully resolved. Mood disorders collectively constitute a leading cause of disability worldwide.
How large is the mental health treatment gap?
The treatment gap — the proportion of people with mental disorders who receive no care — remains the most stark and consistent finding in global mental health data. WHO estimates that more than 75% of people with mental health conditions in low- and middle-income countries receive no treatment at all. Even in high-income countries, the gap is substantial: approximately 50% of Americans with a diagnosable mental disorder do not receive treatment in any given year, per SAMHSA data. For schizophrenia, the gap in low-income countries exceeds 89%. For depression and anxiety, gaps of 50-70% are typical even in countries with universal healthcare systems. Cost, stigma, shortage of trained providers, and geographic access barriers are the primary drivers of the gap.
What is happening with youth mental health?
Youth mental health has deteriorated significantly over the past decade in most high-income countries. US CDC data shows that the percentage of high school students reporting persistent feelings of sadness or hopelessness rose from 28% in 2011 to 42% in 2023. Among adolescent girls, the figure reached 57%. Emergency department visits for self-harm among girls aged 10-14 more than doubled between 2010 and 2022. The UK's NHS reports similar trends, with child and adolescent mental health service referrals reaching record highs in 2024-2025. Researchers debate the role of social media versus other factors (economic stress, climate anxiety, reduced unstructured play), but the scale and consistency of the trend across countries is widely acknowledged as a genuine public health emergency.
What is the economic cost of mental illness?
The Lancet Commission on global mental health estimated that the cumulative global economic cost of mental disorders between 2011 and 2030 would reach \(16 trillion — more than the cost of cancer, diabetes, and respiratory disease combined. In the United States alone, the economic burden of serious mental illness exceeds \)300 billion annually, according to the National Alliance on Mental Illness, including direct treatment costs, lost earnings, and social service expenditures. Mental health conditions are among the leading causes of workplace absenteeism and presenteeism (reduced productivity while at work). Depression alone costs US employers approximately $44 billion annually in lost productivity, according to Journal of Clinical Psychiatry research.
What mental health indicators are actually improving?
Several indicators show genuine improvement. Suicide rates in the United States declined from their 2018 peak (14.2 per 100,000) to approximately 13.2 per 100,000 in 2023, though 2024-2025 preliminary data suggests a potential reversal. Stigma around mental health help-seeking has measurably decreased among younger generations: 64% of Gen Z adults report being comfortable seeking professional mental health help, compared to 48% of Boomers, per American Psychological Association surveys. Telehealth has dramatically expanded access to therapy, with the number of people receiving remote mental health services in the US growing from under 1 million in 2019 to approximately 17 million in 2024. Workplace mental health programs have expanded significantly since 2020.